======= NCOR1 ======= == Gene Information == * **Official Symbol**: NCOR1 * **Official Name**: nuclear receptor corepressor 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9611|9611]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75376|O75376]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NCOR1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NCOR1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600849|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein that mediates ligand-independent transcription repression of thyroid-hormone and retinoic-acid receptors by promoting chromatin condensation and preventing access of the transcription machinery. It is part of a complex which also includes histone deacetylases and transcriptional regulators similar to the yeast protein Sin3p. This gene is located between the Charcot-Marie-Tooth and Smith-Magenis syndrome critical regions on chromosome 17. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 17 and 20.[provided by RefSeq, Jun 2010]. * **UniProt Summary**: Mediates transcriptional repression by certain nuclear receptors. Part of a complex which promotes histone deacetylation and the formation of repressive chromatin structures which may impede the access of basal transcription factors. Participates in the transcriptional repressor activity produced by BCL6. {ECO:0000269|PubMed:14527417}. |Myb DNA-binding| |regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter| |regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter| |regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter| |regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter| |regulation of lipid transport by regulation of transcription from RNA polymerase II promoter| |RNA polymerase II regulatory region DNA binding| |negative regulation of production of miRNAs involved in gene silencing by miRNA| |regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter| |locomotor rhythm| |Sin3 complex| |negative regulation of gene silencing by miRNA| |negative regulation of androgen receptor signaling pathway| |negative regulation of gene silencing by RNA| |negative regulation of posttranscriptional gene silencing| |regulation of production of miRNAs involved in gene silencing by miRNA| |regulation of production of small RNA involved in gene silencing by RNA| |circadian behavior| |rhythmic behavior| |regulation of androgen receptor signaling pathway| |nuclear hormone receptor binding| |regulation of fatty acid transport| |thyroid hormone receptor binding| |negative regulation of JNK cascade| |histone deacetylase complex| |negative regulation of gene silencing| |negative regulation of intracellular steroid hormone receptor signaling pathway| |negative regulation of stress-activated MAPK cascade| |negative regulation of stress-activated protein kinase signaling cascade| |RNA polymerase II activating transcription factor binding| |transcriptional repressor complex| |regulation of organic acid transport| |mitotic spindle| |regulation of intracellular steroid hormone receptor signaling pathway| |regulation of glycolytic process| |regulation of gene silencing by miRNA| |regulation of carbohydrate catabolic process| |regulation of posttranscriptional gene silencing| |regulation of gene silencing by RNA| |regulation of anion transport| |spindle assembly| |regulation of lipid transport| |histone deacetylase binding| |regulation of purine nucleotide metabolic process| |regulation of nucleotide metabolic process| |regulation of ATP metabolic process| |regulation of gene silencing| |regulation of lipid localization| |circadian rhythm| |spindle organization| |regulation of generation of precursor metabolites and energy| |negative regulation of MAPK cascade| |regulation of JNK cascade| |locomotory behavior| |regulation of carbohydrate metabolic process| |transcription regulatory region DNA binding| |regulation of stress-activated MAPK cascade| |regulation of stress-activated protein kinase signaling cascade| |nuclear chromatin| |transcription corepressor activity| |rhythmic process| |chromatin binding| |regulation of lipid metabolic process| |negative regulation of protein phosphorylation| |sequence-specific DNA binding| |regulation of small molecule metabolic process| |negative regulation of phosphorylation| |microtubule cytoskeleton organization| |transcription by RNA polymerase II| |negative regulation of intracellular signal transduction| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |behavior| |negative regulation of protein modification process| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |microtubule-based process| |regulation of ion transport| |chromatin organization| |regulation of cellular response to stress| |regulation of MAPK cascade| |organelle assembly| |negative regulation of transcription by RNA polymerase II| |regulation of catabolic process| |cell cycle process| |negative regulation of cellular protein metabolic process| |chromosome organization| |nucleobase-containing compound biosynthetic process| |negative regulation of protein metabolic process| |cytoskeleton organization| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |cell cycle| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of phosphorylation| |negative regulation of response to stimulus| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |macromolecule biosynthetic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| |regulation of transport| |positive regulation of gene expression| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp169|BH1 1μM R04 exp169]]|-2.77| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.77| |[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-2.67| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-2.25| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-2.12| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-2.11| |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.08| |[[:results:exp277|Curcumin 6.5μM R06 exp277]]|-2.01| |[[:results:exp302|35°C R06 exp302]]|-2| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.93| |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|-1.86| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-1.86| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.86| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.85| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|-1.75| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.37| |[[:results:exp485|GSK626616 14μM R08 exp485]]|2.44| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|2.68| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|3.24| |[[:results:exp502|Milciclib 2μM R08 exp502]]|5.05| ^Gene^Correlation^ |[[:human genes:h:hdac3|HDAC3]]|0.61| |[[:human genes:p:prkaca|PRKACA]]|0.419| |[[:human genes:k:kdsr|KDSR]]|0.412| |[[:human genes:s:srp14|SRP14]]|0.411| |[[:human genes:g:gnas|GNAS]]|0.403| Global Fraction of Cell Lines Where Essential: 2/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6498 * **Expression level (log2 read counts)**: 7.64 {{:chemogenomics:nalm6 dist.png?nolink |}}